Bottom line
XVOL vs VPMCX: the short answer
XVOL (Acruence Active Hedge U.S. Equity ETF) and VPMCX (Vanguard PRIMECAP Fund) are both etfs.
VPMCX is cheaper at 0.35% vs 0.83% — a difference of $48 a year per $10,000 invested.
Over one year, VPMCX returned +29.9% vs +19.9% for XVOL (reporting dates differ).
Updated Nov 19, 2026
XVOL vs VPMCX side by side
| XVOL | VPMCX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Franklin Templeton | Vanguard |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.83% | 0.35% |
| Annual cost per $10k | $83 | $35 |
| 10-yr cost on $10k (prospectus) | $1,025 | $443 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +19.9% | +29.9% |
| 5-yr return (annualized) | — | +14.3% |
| 10-yr return (annualized) | — | +15.2% |
| Best quarter | +13.1% | +17.3% |
| Worst quarter | −16.5% | −20.2% |
| Net assets (fund) | — | $96.1B |
| Number of holdings | — | 173 |
| Portfolio turnover | 361% | 11% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | XVOL | VPMCX | Difference |
|---|---|---|---|
| 2024 | +19.9% | +13.5% | +6.5% |
| 2023 | +7.3% | +28.1% | −20.8% |
| 2022 | −20.9% | −15.2% | −5.8% |
Source: Fund prospectus bar charts
Holdings overlap
XVOL and VPMCX share none of their top holdings.
XVOL top 10
VPMCX top 10
- Micron Technology Inc — 13.50%
- Intel Corp — 6.80%
- Eli Lilly & Co — 6.76%
- KLA Corp — 3.85%
- Alphabet Inc — 3.52%
- AstraZeneca PLC — 2.35%
- NVIDIA Corp — 2.33%
- Amazon.com Inc — 2.05%
- Tesla Inc — 1.89%
- Biogen Inc — 1.88%
FAQ
What is the difference between XVOL and VPMCX?
XVOL (Acruence Active Hedge U.S. Equity ETF) and VPMCX (Vanguard PRIMECAP Fund) are both etfs. VPMCX is cheaper at 0.35% vs 0.83% — a difference of $48 a year per $10,000 invested.
Which is cheaper, XVOL or VPMCX?
VPMCX has the lower expense ratio (0.35%).
Should I own both XVOL and VPMCX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.